In addition, increased expression of TTF-1/NKX2-1 in alveolar type II cells has been found to induce dose-dependent alterations in alveolar morphology, epithelial cell hyperplasia, emphysema, and pulmonary inflammation [22,23]. The gene discussed is NKX2-1; the disease is pulmonary emphysema.